Skip to Content


In the US, Ciclesonide (ciclesonide systemic) is a member of the drug class inhaled corticosteroids and is used to treat Asthma and Asthma - Maintenance.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiasthmatic agent

Antiallergic agent

Glucocorticoid, inhalative

Chemical Names


(R)-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal wit cyclohexanecarboxaldehyde, 21-isobutyrate (WHO)

16alpha,17-[(R)-Cyclohexylmetylendioxy]-11beta,21-dihydroxypregna-1,4-dien-3,20-dion 21-isobutyrat (IUPAC)

Pregna-1,4-diene-3,20-dione, 16,17-(((R)-cyclohexylmetylene)bis)oxy-11-hydroxy-21-(2-metyl-1-oxopropoxy)-, (11beta,16α)-

Pregna-1,4-diene-3,20-dione, 16,17-((cyclohexylmetylene)bis(oxy))-11-hydroxy-21-(2-metyl-1-oxopropoxy)-, (11beta,16α(R))-

Foreign Names

  • Ciclesonidum (Latin)
  • Ciclesonid (German)
  • Ciclésonide (French)
  • Ciclesonida (Spanish)

Generic Names

  • Ciclesonide (OS: USAN, JAN, BAN)
  • B-9207-015 (IS: Byk Gulden)
  • BY-9010 (IS: Byk Gulden)
  • EL-876 (IS)
  • RPR 251526 (IS)
  • Ciclesonid (PH: Ph. Eur. 8)
  • Ciclesonide (PH: BP 2016, Ph. Eur. 8)
  • Ciclésonide (PH: Ph. Eur. 8)
  • Ciclesonidum (PH: Ph. Eur. 8)

Brand Names

  • Alvesco
    3M, Georgia; Altana, Slovakia; Grünenthal, Peru; Grünenthal, Venezuela; Nycomed, Argentina; Nycomed, Bulgaria; Nycomed, Czech Republic; Nycomed, Egypt; Nycomed, Spain; Nycomed, Lithuania; Nycomed, Romania; Nycomed, Serbia; Nycomed, Russian Federation; Nycomed, Turkey; Nycomed, South Africa; Nycomed Pharma, Austria; Nycomed Pharma, Brazil; Sepracor, United States; Takeda, Australia; Takeda, Bosnia & Herzegowina; Takeda, Belgium; Takeda, Colombia; Takeda, Cyprus; Takeda, Germany; Takeda, Finland; Takeda, Greece; Takeda, Hong Kong; Takeda, Croatia (Hrvatska); Takeda, Hungary; Takeda, Ireland; Takeda, Israel; Takeda, Italy; Takeda, Latvia; Takeda, Macedonia; Takeda, Malta; Takeda, Malaysia; Takeda, Netherlands; Takeda, Norway; Takeda, Poland; Takeda, Singapore; Takeda Canada, Canada; Takeda France, France; Takeda GmbH, Estonia; Takeda México, Costa Rica; Takeda México, Dominican Republic; Takeda México, Guatemala; Takeda México, Honduras; Takeda México, Mexico; Takeda México, Nicaragua; Takeda México, Panama; Takeda México, El Salvador; Takeda Pharma, Denmark; Takeda Pharma, Sweden; Takeda UK, United Kingdom; Teijin Pharma, Japan; Takeda Pharma, Switzerland
  • Berosynt
    BCN Medical, Colombia
  • Cesonide HFA
    Beximco, Bangladesh
  • Cinase
    German Remedies, India
  • Disbronc
    Neumobiotics, Chile
  • Ezonide
    Square, Bangladesh
  • Finorinex
    Lafrancol, Colombia
  • Omnair
    Takeda, South Africa
  • Omnaris
    Nycomed, Philippines; Sunovion, United States; Takeda, Argentina; Takeda, Australia; Takeda, Colombia; Takeda, Hong Kong; Takeda, Malaysia; Takeda, Thailand; Takeda Canada, Canada; Takeda México, Dominican Republic; Takeda México, Guatemala; Takeda México, Honduras; Takeda México, Mexico; Takeda México, Panama; Takeda México, El Salvador
  • Zetonna
    Sunovion, United States


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.